A Krauze - Exon Publications, 2021 - exonpublications.com
Glioneuronal tumors are a group of rare neoplasms made up of neural and glial components in heterogenous proportions, generally exhibiting WHO grade I clinical behavior. These …
Q Xie, B Xie, L Ou, M Wang, Z Tang, Y He… - Frontiers in …, 2022 - frontiersin.org
Objective Central neurocytoma (CN) is a rare type of tumor that currently lacks an optimal treatment protocol. This study aimed to explore the clinical outcomes of CN in a cohort of …
L She, D Deng, L Su, C Liu - Journal of Neuro-Oncology, 2022 - Springer
Purpose To investigate the efficacy and safety of adjuvant radiotherapy (RT) in patients with central neurocytoma (CN). Methods The study included 68 patients with CN retrospectively …
Rare central nervous system tumors are defined by an incidence rate of less than 6 cases per 100 000 individuals a year. It comprises a large panel of entities including …
VD Nunno, M Aprile, L Gatto, A Tosoni, L Ranieri… - CNS …, 2024 - Taylor & Francis
Aim: Glioneuronal and neuronal tumors are rare primary central nervous system malignancies with heterogeneous features. Due to the rarity of these malignancies …
A Spina, E Garbin, L Albano, A Bisoglio, N Boari… - Neurosurgical …, 2024 - Springer
Central neurocytomas (CN) are rare tumors within the central nervous system. Originating from the septum pellucidum and subependymal cells, they are typically found in the third …
It is usually difficult to achieve good outcomes with salvage treatment for recurrent nasopharyngeal carcinoma (NPC) because of its deep-seated location, surrounding critical …
Brain tumors are a diverse group of neoplasms arising from different cells within the central nervous system (CNS) or from systemic tumors that have metastasized to the CNS. The …
Central neurocytomas (CNs) are extremely rare tumors that account for 0.1–0.5% of all intracranial neoplasms. Recently, Gamma Knife radiosurgery (GKRS) has become a …